NEUROLOGY 1996;46:1004-1009
© 1996 American Academy of Neurology
Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemiaA comparative study
F. Graus, MD,
A. Saiz, MD,
J. Sierra, MD,
D. Arbaiza, MD,
M. Rovira, MD,
E. Carreras, MD,
E. Tolosa, MD and
C. Rozman, MD
From the Service of Neurology (Drs. Graus, Saiz, Arbaiza, and Tolosa), and Postgraduate School of Hematology ``Farreras Valenti'' (Drs. Sierra, Rovira, Carreras, and Rozman), Hospital Clinic i Provincial. Department of Medicine, University of Barcelona, Barcelona, Spain.
Supported in part by grants FIS 91/0231, and 95/0257, Madrid, Spain, and grants JCIF 89/BS, JCIF 91/BS, and JCIF 93/P-CR from the Jose Carreras International Leukemia Foundation.
Received March 27, 1995. Accepted in final form July 12, 1995.
Address correspondence and reprint requests to Dr. Francesc Graus, Service of Neurology, Hospital Clinic i Provincial. Villarroel 170, 08036 Barcelona, Spain.
We retrospectively evaluated the neurologic complications in 425 patients who underwent bone marrow transplant (BMT) (310 allogeneic, 115 autologous) for leukemia.Forty-six patients (11%) developed 47 central and three peripheral neurologic complications. The most common complications were cerebral hemorrhage (3.8%), metabolic encephalopathy (3%), and CNS infections (2%). All CNS infections occurred with allogeneic BMT. Eleven of 16 hemorrhages were subdural hematomas (69%), which were more frequent in autologous (8%) than in allogeneic (0.6%) BMT (p less than 0.0001), and in patients with acute myelogenous leukemia (AML) (5%) than in the remaining leukemia patients (0.8%) (p equals 0.013). Eight of 11 subdural hematomas occurred in AML patients receiving autologous BMT. When we compared patient-, disease-, and transplant-related characteristics of these patients with those without subdural hematoma, only platelet refractoriness correlated with an increased risk of subdural hematoma. The actuarial probability of developing subdural hematoma was 44% in patients with platelet-refractory disease and only 2.5% in the other patients (p less than 0.0001). Ten patients with subdural hematoma did not have surgery and eight had significant clinical improvement associated with reduction or resolution of the hematoma, confirmed by CT scan in six patients. The subdural hematoma was the cause of death in only one patient. This study shows that the frequency of the different neurologic complications varies among types of BMT. Patients undergoing autologous BMT for AML with platelet refractoriness have an increased risk of subdural hematoma that may be treated with conservative measures.
NEUROLOGY 1996;46: 1004-1009
This article has been cited by other articles:
|
|
|
|
 
T. Nishiguchi, K. Mochizuki, M. Shakudo, T. Takeshita, M. Hino, and Y. Inoue
CNS Complications of Hematopoietic Stem Cell Transplantation
Am. J. Roentgenol.,
April 1, 2009;
192(4):
1003 - 1011.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Denier, J. -H. Bourhis, C. Lacroix, S. Koscielny, J. Bosq, R. Sigal, G. Said, and D. Adams
Spectrum and prognosis of neurologic complications after hematopoietic transplantation
Neurology,
December 12, 2006;
67(11):
1990 - 1997.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D Beckett and J Olliff
Non-infectious manifestations of stem cell transplantation
Br. J. Radiol.,
March 1, 2005;
78(927):
272 - 281.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Sostak, C.S. Padovan, T.A. Yousry, G. Ledderose, H.-J. Kolb, and A. Straube
Prospective evaluation of neurological complications after allogeneic bone marrow transplantation
Neurology,
March 11, 2003;
60(5):
842 - 848.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Faraci, E. Lanino, G. Dini, M.P. Fondelli, G. Morreale, S. Dallorso, C. Manzitti, M.G. Calevo, R. Gaggero, E. Castagnola, et al.
Severe neurologic complications after hematopoietic stem cell transplantation in children
Neurology,
December 24, 2002;
59(12):
1895 - 1904.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S A Sohaib
Extrapulmonary complications of bone marrow transplantation
Imaging,
August 1, 2002;
14(4):
278 - 284.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. M. Coplin, M. S. Cochran, S. R. Levine, and S. W. Crawford
Stroke after bone marrow transplantation: Frequency, aetiology and outcome
Brain,
May 1, 2001;
124(5):
1043 - 1051.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. L. Antunes
Topical Review: Acute Neurologic Complications in Children With Systemic Cancer
J Child Neurol,
November 1, 2000;
15(11):
705 - 716.
[Abstract]
[PDF]
|
|
|
|
|
|
|
C de Brabander, J Cornelissen, P A E S. Smitt, C. J Vecht, and M J van den Bent
Increased incidence of neurological complications in patients receiving an allogenic bone marrow transplantation from alternative donors
J. Neurol. Neurosurg. Psychiatry,
January 1, 2000;
68(1):
36 - 40.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
M. Wong, G. B. Mallory Jr., J. Goldstein, M. Goyal, and K. A. Yamada
Neurologic complications of pediatric lung transplantation
Neurology,
October 1, 1999;
53(7):
1542 - 1542.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
C. S. Padovan, K. Bise, J. Hahn, P. Sostak, E. Holler, H.-J. Kolb, and A. Straube
Angiitis of the Central Nervous System After Allogeneic Bone Marrow Transplantation?
Stroke,
August 1, 1999;
30(8):
1651 - 1656.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Nevo, V. Swan, C. Enger, K.J. Wojno, R. Bitton, M. Shabooti, A.K. Fuller, R.J. Jones, H.G. Braine, and G.B. Vogelsang
Acute Bleeding After Bone Marrow Transplantation (BMT)--- Incidence and Effect on Survival. A Quantitative Analysis in 1,402 Patients
Blood,
February 15, 1998;
91(4):
1469 - 1477.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
